Sparse modeling reveals miRNA signatures for diagnostics of inflammatory bowel disease

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Hübenthal, Matthias ^a   Hemmrich Stanisak, Georg ^a   Degenhardt, Frauke ^a   Szymczak, Silke ^a   Du, Zhipei ^a   Elsharawy, Abdou ^a,b   Keller, Andreas ^c   Schreiber, Stefan ^a,d   Franke, Andre ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Damietta University   (Egypt)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; MICRORNA; MICRORNA 142 5P; MICRORNA 16; MICRORNA 205; MICRORNA 34B; MICRORNA 424; MICRORNA 99B; TACROLIMUS; UNCLASSIFIED DRUG; MESSENGER RNA; TRANSCRIPTOME;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; PANCREATITIS; RANDOM FOREST; SARCOIDOSIS; SUPPORT VECTOR MACHINE; ULCERATIVE COLITIS; VALIDATION STUDY; AGED; ALGORITHM; BIOLOGY; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; RNA INTERFERENCE; STATISTICAL MODEL; YOUNG ADULT;

ADULT; AGED; ALGORITHMS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICRORNAS; MIDDLE AGED; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, MESSENGER; SUPPORT VECTOR MACHINE; TRANSCRIPTOME; YOUNG ADULT;

EID: 84948978330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140155     Document Type: Article

References (83)

1. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology. 2006; 131: 366-78. doi: 10.1053/j.gastro.2006.04.030 PMID: 16890590
2. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut. 1997; 40: 328-32. PMID: 9135520
3. Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011; 140: 1817-1826.e2. doi: 10.1053/j.gastro.2010.11.058 PMID: 21530748
4. Iskandar HN, Ciorba M. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res. Mosby, Inc.; 2012; 159: 313-25. doi: 10.1016/j.trsl.2012.01.001 PMID: 22424434
5. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. Nature Publishing Group; 2012; 491: 119-24. doi: 10.1038/nature11582 PMID: 23128233
6. Jostins L, Barrett JC. Genetic Risk Prediction in Complex Disease. Hum Mol Genet. 2011; 1-7. doi: 10. 1093/hmg/ddr378
7. Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE. Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet. 2009; 5: e1000337. doi: 10.1371/journal.pgen.1000337 PMID: 19197355
8. Clark PM, Dawany N, Dampier W, Byers SW, Pestell RG, Tozeren A. Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflamm Bowel Dis. 2012; 18: 2315-33. doi: 10.1002/ibd.22958 PMID: 22488912
9. Gologan S, Iacob R, Iancu D, Iacob S, Cotruta B, Vadan R, et al. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol. J Crohns Colitis. European Crohn's and Colitis Organisation; 2013; 7: 622-30. doi: 10.1016/j.crohns.2012.08.015 PMID: 23014361
10. van Lierop PPE, Swagemakers SM, de Bie CI, Middendorp S, van Baarlen P, Samsom JN, et al. Gene expression analysis of peripheral cells for subclassification of pediatric inflammatory bowel disease in remission. PLoS One. 2013; 8: e79549. doi: 10.1371/journal.pone.0079549 PMID: 24260248
11. Montero-Meléndez T, Llor X, García-Planella E, Perretti M, Suárez A. Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling. PLoS One. 2013; 8: e76235. doi: 10.1371/journal.pone.0076235 PMID: 24155895
12. Granlund AVB, Flatberg A, Østvik AE, Drozdov I, Gustafsson BI, Kidd M, et al. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis. PLoS One. 2013; 8: e56818. doi: 10.1371/ journal.pone.0056818 PMID: 23468882
13. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet. Nature Publishing Group; 2011; 43: 242-5. doi: 10.1038/ng.762 PMID: 21278745
14. Chen W-X, Ren L-H, Shi R-H. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol. 2014; 5: 63-70. doi: 10.4291/wjgp.v5.i2.63 PMID: 24891977
15. Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, et al. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol. 2013; 173: 250-8. doi: 10.1111/cei.12104 PMID: 23607522
16. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, Bayless TM, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2011; 17: 241-50. doi:10.1002/ ibd.21450 PMID: 20812331
17. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis. 2010; 16: 1729-38. doi: 10. 1002/ibd.21267 PMID: 20848482
18. Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr. 2011; 53: 26-33. doi: 10.1097/MPG. 0b013e31822200cc PMID: 21546856
19. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, et al. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One. 2010; 5. doi: 10.1371/journal.pone.0013160
20. Zahm AM, Hand NJ, Tsoucas DM, Le Guen CL, Baldassano RN, Friedman JR. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon. J Crohns Colitis. European Crohn's and Colitis Organisation; 2014; doi: 10.1016/j.crohns.2014.02.012
21. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology. 2008; 135: 1624-1635.e24. doi: 10.1053/j.gastro.2008.07.068 PMID: 18835392
22. Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis. European Crohn's and Colitis Organisation; 2012; 6: 900-4. doi: 10.1016/j.crohns.2012.02.006 PMID: 22386737
23. Ghorpade DS, Sinha AY, Holla S, Singh V, Balaji KN. NOD2-nitric oxide-responsive microRNA-146a activates sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem. 2013; doi: 10.1074/jbc.M113.492496
24. Kanaan Z, Rai SN, Eichenberger MR, Barnes C, Dworkin AM, Weller C, et al. Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat. 2012; 33: 551-60. doi: 10.1002/humu.22021 PMID: 22241525
25. Li Z, Wu F, Brant SR, Kwon JH. IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J Immunol. 2011; 186: 6182-90. doi: 10.4049/jimmunol.1000917 PMID: 21508257
26. Koukos G, Polytarchou C, Kaplan JL, Morley-Fletcher A, Gras-Miralles B, Kokkotou E, et al. MicroRNA- 124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology. Elsevier, Inc; 2013; 145: 842-52.e2. doi: 10.1053/j.gastro.2013.07.001 PMID: 23856509
27. Chuang AY, Chuang JC, Zhai Z, Wu F, Kwon JH. NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells. Inflamm Bowel Dis. 2014; 20: 126-35. doi: 10.1097/01.MIB. 0000436954.70596.9b PMID: 24297055
28. Chen Y, Wang C, Liu Y, Tang L, Zheng M, Xu C, et al. miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn's disease. Biochem Biophys Res Commun. Elsevier Inc.; 2013; 438: 133-9. doi: 10.1016/j.bbrc.2013.07.040 PMID: 23872065
29. Feng X, Wang H, Ye S, Guan J, Tan W, Cheng S, et al. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One. 2012; 7: e52782. doi: 10.1371/journal.pone.0052782 PMID: 23285182
30. Thu Nguyen HT, Dalmasso G, Müller S, Carrière J, Seibold F, Darfeuille-Michaud A. Crohn's Diseaseassociated Adherent Invasive Escherichia coli Affect Levels of microRNAs in Intestinal Epithelial Cells to Reduce Autophagy. Gastroenterology. Elsevier Ltd; 2013; doi: 10.1053/j.gastro.2013.10.021
31. Zhai Z, Wu F, Chuang AY, Kwon JH. miR-106b Fine Tunes ATG16L1 Expression and Autophagic Activity in Intestinal Epithelial HCT116 Cells. 2013; 19: 17-19. doi: 10.1097/MIB.0b013e31829e71cf
32. Shi C, Liang Y, Yang J, Xia Y, Chen H, Han H, et al. MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury. PLoS One. 2013; 8: e66814. doi: 10.1371/journal.pone.0066814 PMID: 23826144
33. Yang Y, Ma Y, Shi C, Chen H, Zhang H, Chen N, et al. Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. Biochem Biophys Res Commun. Elsevier Inc.; 2013; 434: 746-52. doi: 10.1016/j.bbrc.2013.03.122 PMID: 23583411
34. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, et al. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis. 2011; 17: 221-31. doi: 10.1002/ibd.21359 PMID: 20848542
35. Olaru AV, Yamanaka S, Vazquez C, Mori Y, Cheng Y, Abraham JM, et al. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis. 2013; 19: 471-80. doi: 10.1097/MIB.0b013e31827e78eb PMID: 23399735
36. Ludwig K, Fassan M, Mescoli C, Pizzi M, Balistreri M, Albertoni L, et al. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch. 2013; 462: 57-63. doi: 10. 1007/s00428-012-1345-5 PMID: 23224068
37. Cortes C, Vapnik V. Support-Vector Networks. Mach Learn. 1995; 20: 273-297.
38. Breiman L. Random Forests. Mach Learn. 2001; 45: 5-32.
39. Keller A, Leidinger P, Bauer A, ElSharawy A, Haas J, Backes C, et al. Toward the blood-borne miRNome of human diseases. Nat Methods. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2011; 8: 841-843. doi: 10.1038/nmeth.1682 PMID: 21892151
40. Keller A, Leidinger P, Steinmeyer F, Stähler C, Franke A, Hemmrich-Stanisak G, et al. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler. 2014; 20: 295-303. doi: 10.1177/1352458513496343 PMID: 23836875
41. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One. 2009; 4: e7440. doi: 10.1371/journal.pone.0007440 PMID: 19823682
42. Keller A, Backes C, Leidinger P, Kefer N, Boisguerin V, Barbacioru C, et al. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Mol Biosyst. 2011; 7: 3187-99. doi: 10.1039/c1mb05353a PMID: 22027949
43. Abu-Halima M, Hammadeh M, Backes C, Fischer U, Leidinger P, Lubbad AM, et al. A panel of five microRNAs as potential biomarkers for the diagnosis and assessment of male infertility. Fertil Steril. 2014; doi: 10.1016/j.fertnstert.2014.07.001
44. Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnæs E, et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer. 2011; 104: 830-40. doi: 10.1038/bjc.2011.29 PMID: 21326242
45. Keutgen XM, Filicori F, Crowley MJ, Wang Y, Scognamiglio T, Hoda R, et al. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res. 2012; 18: 2032-8. doi: 10.1158/1078-0432.CCR-11-2487 PMID: 22351693
46. Patnaik SK, Yendamuri S, Kannisto E, Kucharczuk JC, Singhal S, Vachani A. MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLoS One. 2012; 7: e46045. doi: 10.1371/journal. pone.0046045 PMID: 23029380
47. Miotto P, Mwangoka G, Valente IC, Norbis L, Sotgiu G, Bosu R, et al. miRNA signatures in Sera of patients with active pulmonary tuberculosis. PLoS One. 2013; 8: e80149. doi: 10.1371/journal.pone. 0080149 PMID: 24278252
48. Duttagupta R, DiRienzo S, Jiang R, Bowers J, Gollub J, Kao J, et al. Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis. PLoS One. 2012; 7: e31241. doi: 10.1371/journal.pone. 0031241 PMID: 22359580
49. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction (Springer Series in Statistics). 2nd ed. 2009.
50. Güimil R, Beier M, Scheffler M, Rebscher H, Funk J, Wixmerten A, et al. Geniom technology-the benchtop array facility. Nucleosides Nucleotides Nucleic Acids. 22: 1721-3. doi: 10.1081/NCN- 120023122 PMID: 14565504
51. Vorwerk S, Ganter K, Cheng Y, Hoheisel J, Stähler PF, Beier M. Microfluidic-based enzymatic on-chip labeling of miRNAs. N Biotechnol. 25: 142-9. doi: 10.1016/j.nbt.2008.08.005 PMID: 18786664
52. Huber W, von Heydebreck A, Sueltmann H, Poustka A, Vingron M. Parameter estimation for the calibration and variance stabilization of microarray data. Stat Appl Genet Mol Biol. 2003; 2. doi: 10.2202/ 1544-6115.1008
53. Bradley PS, Mangasarian OL. Feature Selection via Concave Minimization and Support Vector Machines. Proceedings of the Fifteenth International Conference on Machine Learning ICML '98. San Francisco, CA, USA: Morgan Kaufmann Publishers Inc.; 1998. pp. 82-90.
54. Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B (Statistical Methodol. 2005; 67: 301-320.
55. Zhang HH, Ahn J, Lin X, Park C. Gene selection using support vector machines with non-convex penalty. Bioinformatics. 2006; 22: 88-95. doi: 10.1093/bioinformatics/bti736 PMID: 16249260
56. Becker N, Toedt G, Lichter P, Benner A. Elastic SCAD as a novel penalization method for SVM classification tasks in high-dimensional data. BMC Bioinformatics. BioMed Central Ltd; 2011; 12: 138. doi: 10. 1186/1471-2105-12-138 PMID: 21554689
57. Becker N, Werft W, Toedt G, Lichter P, Benner A. penalizedSVM: a R-package for feature selection SVM classification. Bioinformatics. 2009; 25: 1711-1712. doi: 10.1093/bioinformatics/btp286 PMID: 19398451
58. Friedman JH. Another approach to polychotomous classification. 1996.
59. Szymczak S, Holzinger E, Dasgupta A, Malley J, Molloy A, Mills J, et al. r2VIM: A new variable selection method for random forests in genome-wide association studies. submitted.
60. Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods. 2009; 14: 323-48. doi: 10.1037/a0016973 PMID: 19968396
61. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005; 21: 3940-1. doi: 10.1093/bioinformatics/bti623 PMID: 16096348
62. Hsu S-D, Tseng Y-T, Shrestha S, Lin Y-L, Khaleel A, Chou C-H, et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2014; 42: D78-85. doi: 10.1093/nar/gkt1266 PMID: 24304892
63. Franke A, McGovern DPB, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010/11/26 ed. 2010; 42: 1118-1125. doi: 10.1038/ng.717 PMID: 21102463
64. Blunt MD, Ward SG. Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia. Curr Opin Pharmacol. 2012; 12: 444-51. doi: 10.1016/j.coph.2012.02.015 PMID: 22483603
65. Chen Y, Xiao Y, Ge W, Zhou K, Wen J, Yan W, et al. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis. 2013; 4: e541. doi: 10.1038/cddis.2013.22 PMID: 23492772
66. Ying L, Marino J, Hussain SP, Khan MA, You S, Hofseth AB, et al. Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res. 2005; 65: 9132-6. doi: 10. 1158/0008-5472.CAN-05-1358 PMID: 16230367
67. Frey MR, Brent Polk D. ErbB receptors and their growth factor ligands in pediatric intestinal inflammation. Pediatr Res. 2014; 75: 127-32. doi: 10.1038/pr.2013.210 PMID: 24402051
68. Khor TO, Huang M-T, Kwon KH, Chan JY, Reddy BS, Kong A-N. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 2006; 66: 11580-4. doi: 10.1158/ 0008-5472.CAN-06-3562 PMID: 17178849
69. Bian Z, Li L, Cui J, Zhang H, Liu Y, Zhang C-Y, et al. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol. 2011; 225: 544-53. doi: 10.1002/path.2907 PMID: 21590770
70. Balzola F, Bernstein C, Ho GT, Russell RK. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease: Commentary. 2011/10/11 ed. Inflammatory Bowel Disease Monitor. 2012. pp. 126-127.
71. Gerlach K, Hwang Y, Nikolæv A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014; 15: 676-86. doi: 10.1038/ni.2920 PMID: 24908389
72. Marcil V, Sinnett D, Seidman E, Boudreau F, Gendron F-P, Beaulieu J-F, et al. Association between genetic variants in the HNF4A gene and childhood-onset Crohn's disease. Genes Immun. Nature Publishing Group; 2012; 13: 556-65. doi: 10.1038/gene.2012.37 PMID: 22914433
73. Diegelmann J, Czamara D, Le Bras E, Zimmermann E, Olszak T, Bedynek A, et al. Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2. PLoS One. 2013; 8: e77773. doi: 10. 1371/journal.pone.0077773 PMID: 24223725
74. Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA, Phillips A, et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. 2009; 41: 1330-4. doi: 10.1038/ng.483 PMID: 19915572
75. + T cells, in mice and humans. Gastroenterology. 2011; 140: 550-9. doi: 10.1053/j.gastro.2010.10.057 PMID: 21056041
76. Sipos F, Galamb O, Herszényi L, Molnár B, Solymosi N, Zágoni T, et al. Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis. Scand J Gastroenterol. 2008; 43: 289-98. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 18938767 PMID: 18938767
77. Andoh A, Saotome T, Sato H, Tsujikawa T, Araki Y, Fujiyama Y, et al. Epithelial expression of caveolin- 2, but not caveolin-1, is enhanced in the inflamed mucosa of patients with ulcerative colitis. Inflamm Bowel Dis. 2001; 7: 210-4. Available: http://www.ncbi.nlm.nih.gov/pubmed/11515846 PMID: 11515846
78. Bouzid D, Fourati H, Amouri A, Marques I, Abida O, Haddouk S, et al. Association of the RAVER2 gene with increased susceptibility for ulcerative colitis. Hum Immunol. 2012; 73: 732-5. doi: 10.1016/j. humimm.2012.04.018 PMID: 22561236
79. Bhonde MR, Gupte RD, Dadarkar SD, Jadhav MG, Tannu AA, Bhatt P, et al. A novel mTOR inhibitor is efficacious in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol. 2008; 295: G1237-45. doi: 10.1152/ajpgi.90537.2008 PMID: 18927209
80. Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol. 1997; 107: 135-40. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1904558&tool=pmcentrez&rendertype=abstract PMID: 9010268
81. Schulmann K, Mori Y, Croog V, Yin J, Olaru A, Sterian A, et al. Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology. 2005; 129: 74-85. Available: http://www.ncbi.nlm.nih.gov/pubmed/16012936 PMID: 16012936
82. Deng H, Runger G. Gene selection with guided regularized random forest. 2012; Available: http://arxiv. org/abs/1209.6425
83. Liu JZ, Anderson C. Genetic studies of Crohn's disease: past, present and future. Best Pract Res Clin Gastroenterol. Elsevier Ltd; 2014; 28: 373-86. doi: 10.1016/j.bpg.2014.04.009 PMID: 24913378